Rapid plasma virus and CD4+ T-cell turnover in HIV-1 infection: Evidence for an only transient interruption by treatment

AIDS

Volumn 10, Issue 8, 1996, Pages 849-857

  Stellbrink, Hans Jürgen ^a   Zöller, Bernhard ^a   Fenner, Thomas ^a   Lichtenberg, Gerwald ^b   Van Lunzen, Jan ^a   Albrecht, Helmut ^a   Thiele, Heinz Günter ^a   Greten, Heiner ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Universitatskrankenhaus Eppendorf ^*

Author keywords

Antiretroviral treatment; CD4+ T cell turnover; Viral kinetics; Virus turnover

Indexed keywords

ANTIGEN P24; BETA 2 MICROGLOBULIN; CD4 ANTIGEN; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE SUBPOPULATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029980244     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199607000-00008     Document Type: Article

References (33)

1. Van Kerckhoven I, Fransen KR, Peeters M, et al.: Quantification of human immunodeficiency virus in plasma by RNA PCR, viral culture, and p24 antigen detection. J Clin Microbiol 1994, 32:1669-1673.
2. Piatak M Jr, Saag MS, Yang LC, et al.: Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction. AIDS 1993, 7 (suppl 2):S65-S71.
3. Khadir A, Coutlee F, Saint-Antoine P, et al.: Clinical evaluation of Amplicor HIV-1 test for detection of human immunodeficiency virus type 1 proviral DNA in peripheral blood mononuclear cells. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 9:257-263.
4. Nuovo GJ, Becker J, Burk MW, et al.: In situ detection of PCR-amplified HIV-1 nucleic acids in lymph nodes and peripheral blood in patients with asymptomatic HIV-1 infection and advanced-stage AIDS. J Acquir Immune Defic Syndr 1994, 7:916-923.
5. Sei S, Kleiner DE, Kopp JB, et al.: Quantitative analysis of viral burden in tissues from adults and children with symptomatic human immunodeficiency virus type 1 infection assessed by polymerase chain reaction. J Infect Dis 1994, 170:325-333.
6. Katzenstein T, Pedersen C, Nielsen C, et al.: Longitudinal serum HIV RNA quantification. Correlation to viral phenotype at seroconversion. V European Conference on the Clinical Aspects of Treatment in HIV Infection. Copenhagen, September 1995 [abstract 73].
7. Alcabes P, Schoenbaum EE, Klein RS: CD4+ lymphocyte level and rate of decline as predictors of AIDS in intravenous drug users with HIV infection. AIDS 1993, 7:513-517.
8. Margolick JB, Munoz A, Vlahov D, et al.: Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection. JAMA 1992, 267:1631-1636.
9. Aledort LM, Hilgartner MW, Pike MC, et al.: Variability in serial CD4 counts and relation to progression of HIV-1 infection to AIDS in haemophilic patients. BMJ 1992, 304:212-216.
10. Ho DD, Neumann AU, Perelson AS, et al.: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995, 373:123-126.
11. Wei X, Ghosh SK, Taylor ME, et al.: Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995, 373:117-122.
12. Yarchoan R, Mitsuya H, Myers CE, et al.: Clinical pharmacology of 3′-azido-2′,3′-dideoxythymidine (zidovudine) and related dideoxynucleosides. N Engl J Med 1989, 321:726-738.
13. Crowe SM, McGrath MS, Elbeik T, et al.: Comparative assessment of antiretrovirals in human monocyte-macrophages and lymphoid cell lines acutely and chronically infected with the human immunodeficiency virus. J Med Virol 1989, 29:176-180.
14. Perno CF, Bergamini A, Pesce CD, et al.: Inhibition of the protease of human immunodeficiency virus blocks replication and infectivity of the virus in chronically infected macrophages. J Infect Dis 1993, 168:1148-1156.
15. Wahlberg J, Albert J, Lundeberg J, et al.: Dynamic changes in HIV-1 quasispecies from azidothymidine (AZT)-treated patients [abstract]. FASEB J 1995, 6:2843-2847.
16. Ljung L: System Identification - Theory For The User. Englewood Cliffs: Prentice-Hall; 1987.
17. Loveday C, Kaye S, Tenant-Flowers M, et al.: HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy. Lancet 1995, 324:820-824.
18. Poli G, Orenstein JM, Kinter A, et al.: Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines. Science 1989, 244:575-577.
19. Yerly S, Chamot E, Hirschel B, et al.: Quantification of human immunodeficiency virus provirus and circulating virus: relationship with immunologie parameters. J Infect Dis 1992, 166:269-276.
20. Bebenek K, Abbotts J, Wilson SH, et al.: Error-prone polymerization by HIV-1 reverse transcriptase. Contribution of template-primer misalignment, miscoding, and termination probability to mutational hot spots. J Biol Chem 1993, 268:10324-10334.
21. Pattullo A, Patenaude P, Merzouki A, et al.: Quantification of HIV-1 cellular and plasma RNA during combination antiretroviral treatment. Second National Conference on Human Retroviruses and Related Infections. Washington, January 1995 [abstract 117].
22. Finkel TH, Tudor-Williams G, Banda NK, et al.: Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nature Med 1995, 1:129-134.
23. Hughes MD, Stein DS, Gundacker HM, et al.: Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. J Infect Dis 1994, 169:28-36.
24. 2-microglobulin by normal and malignant human cell lines and peripheral lymphocytes. Transplant Rev 1974, 21:53-84.
25. 2-M-microglobulin during infectious mononucleosis. Clin Immunol Immunopathol 1982, 24:55-62.
26. 2-microglobulin by stimulated lymphocytes. J Immunol 1972, 109:407-409.
27. 2-microglobulin production by highly purified human T and B lymphocytes in cell culture stimulated with various antigens. J Immunol 1979, 36:417-453.
28. Schmitz I, van Lunzen J, Tenner-Racz K, et al.: Follicular dendritic cells retain HIV-1 particles on their plasma membrane, but are not productively infected in asymptomatic patients with follicular hyperplasia. J Immunol 1994, 153:1352-1359.
29. Kobayashi K, Takeda A, Green S, et al.: Direct detection of infectious human immunodeficiency virus type 1 (HIV-1) immune complexes in the sera of HIV-1-infected persons. J Infect Dis 1993, 168:729-732.
30. Mosier DE: HIV results in the frame: CD4+ cell turnover [letter]. Nature 1995, 375:193-194.
31. Sprent J, Tough D: HIV results in the frame: CD4+ cell turnover [letter]. Nature 1995, 375:194.
32. Dimitrov DS, Martin MA: HIV results in the frame: CD4+ cell turnover [letter]. Nature 1995, 375:194-195.
33. Phillips AN, Sabin CA, Mocroft A, et al.: HIV results in the frame: antiviral therapy [letter]. Nature 1995, 375:195.